ENTITY
SillaJen Inc

SillaJen Inc (215600 KS)

52
Analysis
Health Care • South Korea
SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.
more
•13 Sep 2019 08:23

Asia Short Interest - Scary Charts for Friday the 13th

In keeping with the day of the week and date, we look at some charts of short interest and price for stocks from Korea, Taiwan and Hong Kong.These...

Logo
912 Views
Share
•04 Sep 2019 07:06

Korea Short Interest - SillaJen Tends to Zero

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 30 August.Current...

Logo
632 Views
Share
•21 Aug 2019 05:40

Korea Short Interest - Numb3rs & Ch@rts

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 16 August. Current...

Logo
640 Views
Share
bullish•Icure Pharm Inc
•02 Jun 2018 11:48

Icure Pharm IPO Summary - Front Runner of Dementia Patch Development Race

Icure Pharm Inc (175250 KS)Ā will offer a total ofĀ 1,200,000 shares (100% new rights offering) atĀ ā‚©44,000 - ā‚©55,000 which gives a market cap of...

Logo
453 Views
Share
bullish•SillaJen Inc
•25 Oct 2017 14:03

SillaJen - Pipeline Review & Valuation Study

I surely understandĀ SillaJen, Inc. (0908477D KS) is a very speculative stock to invest right now. It has virtually no revenue. We still have to...

Logo
533 Views
Share
x